• NCVTC to develop host-directed antivirals for COVID 19 expresspharma
    June 05, 2020
    The selected candidates (hits) with anti-coronavirus activity will be subjected to study of their molecular mechanism of action, besides examining generation of potential drug-resistant virus variants.
PharmaSources Customer Service